Guardant Health has developed a new FDA-approved blood test designed to detect colorectal cancer, and it's now available to patients in North Texas.

By Rebecca Dzombak Climate change is coming for something surprising: the world’s blood supply. Warming and extreme weather can slow blood donations, disrupt blood transport and risk the safety ...

An AST blood test measures levels of aspartate aminotransferase (AST) and helps determine liver function. Less than 40 IU/L is normal, but too much of this enzyme can indicate a problem ...

With President Trump’s latest tariffs underway, a group of House Democrats are calling on the administration to try to protect medical supply chains from the “devastating consequences” the ...

A novel blood test that detects a key biomarker for Alzheimer’s disease (AD) could help physicians more accurately determine the presence and track disease progression. The test measures levels ...

The color of a person’s period blood can indicate different health conditions. For example, a bright red period indicates a healthy flow, while darker red or dark brown can signify pregnancy.

Drinking water can help support healthy blood pressure, but it doesn’t usually lower it unless you’re dehydrated. Since blood is about 90% water, dehydration can reduce blood volume and cause blood ...

For years, Dominique McShain dreamed of becoming a psychologist for troubled youth in her native New Zealand. She was on track to achieve her goal, studying psychology in college, but in April ...

The UK’s medicine supply could be disrupted by sweeping tariffs imposed by Donald Trump, the health secretary has warned, saying cabinet ministers are doing their best to mitigate the impacts of ...

Now on the horizon is an innovative platform for the detection of colorectal cancer using a simple blood sample. The OncoRedox system ... which focus mainly on detecting colon cancer via stool samples ...

The QC program started 2009 with the aim to standardize CSF biomarker measurements between both research and clinical laboratories and since 2019 the program extended to also include blood biomarkers.